Medtronic Deal Highlights FTC Focus On Future Competition
The Federal Trade Commission recently green-lighted Medtronic Inc.'s $42.9 billion acquisition of Covidien PLC after Medtronic agreed to a settlement that requires Medtronic to divest its drug-coated balloon catheter products to...To view the full article, register now.
Already a subscriber? Click here to view full article